Arrowstreet Capital, Limited Partnership Johnson & Johnson Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Johnson & Johnson stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 3,301,356 shares of JNJ stock, worth $554 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
3,301,356
Previous 2,366,660
39.49%
Holding current value
$554 Million
Previous $342 Million
59.96%
% of portfolio
0.45%
Previous 0.28%
Shares
29 transactions
Others Institutions Holding JNJ
# of Institutions
4,640Shares Held
1.73BCall Options Held
25MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA234MShares$39.3 Billion0.72% of portfolio
-
Black Rock Inc. New York, NY198MShares$33.3 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$22.5 Billion0.94% of portfolio
-
Geode Capital Management, LLC Boston, MA59.4MShares$9.97 Billion0.79% of portfolio
-
Jpmorgan Chase & CO New York, NY54.1MShares$9.08 Billion0.7% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $439B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...